Article Details

CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application ...

Retrieved on: 2021-03-08 03:42:22

Tags for this article:

Click the tags to see associated articles and topics

CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application .... View article details on hiswai:

Excerpt

Its anti-PCSK9 monoclonal antibody was the first in China to be approved for clinical trials by the NMPA. In early 2020, Junshi Biosciences joined forces ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up